Healthcare -
Biotechnology - NASDAQ - US
$ 9.75
0.619 %
$ 752 M
Market Cap
-3.18
P/E
REPL - OPERATING INCOME
Operating Income REPL - Replimune Group, Inc.
-235 M
LAST VALUE
-40.87%
2 YEAR CAGR
-49.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR